Alpa M. Nick

机构：Texas Oncology · ORCID：0000-0001-9232-1458

发表论文 384 篇 · 总被引 11555 次 · h-index 59

代表论文

Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial (2024 · Med · 被引 7)
Clinical Features and Voxel-Based-Symptom-Lesion Mapping of Silent Aspiration in Acute Infratentorial Stroke (2023 · Dysphagia · 被引 4)
Abstract A121: Temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer (2023 · Molecular Cancer Therapeutics · 被引 1)
Correction: Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer (2024 · PLoS ONE)
Phase II Trial of Pembrolizumab in Combination with Chemotherapy for Frontline Treatment of Advanced Epithelial Ovarian Cancer (2024 · SSRN Electronic Journal)
Data from A Novel Platform for Detection of CK+ and CK− CTCs (2023)